You are here: Home / About Us

Exclcirc (Suzhou) Biomedical co.,Ltd

Exclcirc (Suzhou) Biomedical co.,Ltd, was co-founded by Dr. Ge Shan, an expert in the field of circ RNA, and Dr. Dongsheng Dai, a veteran with extensive experience in the industry, who has made outstanding achievements in the field of circ RNA research over the years, providing a solid scientific foundation for our company.
Our core technology is an innovative enhanced circ RNA technology with significant advantages over other circ RNA technology. The development of this technology, which is based on the long-term research results of Prof. Ge Shan, has enabled us to synthesize circ RNA in a more efficient and controllable manner, providing a powerful tool for medical and biological research.

In addition to the innovative technological approach, our company is backed by multiple technology patents. These patents cover our innovations, safeguard our research outcomes, and ensure our leading position in the market. These patents will help deter unauthorized competitors from using our technology, providing a stable competitive advantage for our company.

In summary, our company's discovery of circ RNA preparation and new methods is poised to usher in a new era in the field of life sciences. We firmly believe that this innovation will present unprecedented opportunities in fields such as healthcare, biotechnology, and pharmaceutical research, driving revolutionary changes in the realms of health and medicine. We look forward to collaborating with partners from various sectors to explore the boundless potential of this innovation and collectively shape the future of science and technology.

The Characteristics of Exclcirc RNA

Our Team

Creating a new class of therapeutics requires thinking outside the lines. Comprised of a team of skilled scientists, molecular engineers, and industry veterans in addition to a world class Board, we are well-suited for the challenge of bringing the promise of our oRNATM therapeutics to patients.

Intellectual property rights

Back to the top